Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
11/2000
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369999A1 Enzymatically activated polymeric drug conjugates
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/01/2000CN1058009C 8-oxy-5,8-dihydro-6H-dibenzo [a,g] quinolizine -13-propionic acid derivant, its preparation method and medicinal use thereof
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
10/2000
10/31/2000US6140357 Small molecule inhibitors of rotamase enzyme activity
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/27/2000CA2307104A1 Human myoblast cell lines and their uses
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063402A1 Cassette regulating the expression of a heterologous nucleic acid in a eucaryotic cell, especially a muscle cell
10/26/2000WO2000063396A1 Method for enhancing myoblast migration and invasion in the context of gene therapy
10/26/2000WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063203A1 Piperidine-indole compounds having 5-ht6 affinity
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000CA2370617A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2366125A1 Cassette regulating the expression of a heterologous nucleic acid in a eucaryotic cell, especially a muscle cell
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045693A1 Aminophenoxyacetic acid derivatives as neuroprotectants
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
10/24/2000US6136861 Bicyclo[2.2.1]heptanes and related compounds
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061606A1 Novel human voltage-gated potassium channel
10/19/2000WO2000061189A2 Water-soluble compositions of bioactive lipophilic compounds
10/19/2000WO2000061188A1 Sodium channel blocker compositions and the use thereof
10/19/2000WO2000060950A1 Dietary supplement derived from fermented milks for the prevention of osteoporosis
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000DE19915602A1 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-4-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000DE19915601A1 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-3-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000DE19915465A1 Verwendung eines Caspase-Inhibitors zur Proliferationshemmung von Zellen und Verwendung eines oder mehrerer Caspase-Inhibitors/en zur Behandlung von Erkrankungen beruhend auf Lymphozyten-Hyperproliferation oder zur Suppression einer Immunantwort durch Lymphozyten Using a Caspase inhibitor for the inhibition of proliferation of cells and using one or more caspase inhibitor / s for the treatment of diseases based on lymphocyte hyperproliferation or for suppression of an immune response by lymphocytes
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2369822A1 Novel human voltage-gated potassium channel
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/18/2000EP1044203A1 3'-epimeric k-252a derivatives
10/18/2000EP1044202A1 1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides
10/18/2000CN1270163A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270162A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1057525C Process improvement in synthesis of N-[3-(3-cyanopyrazolo [1,5-alpha] pyrimidin-7-yl] phenyli-N-ethyl-acetamide
10/18/2000CN1057456C Wind-dispelling ointment and preparation method thereof
10/12/2000WO2000060100A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000WO2000060099A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000WO2000060098A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000059942A2 Human obesity protein binding protrein-2 homolog and uses thereof
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059940A2 Platelet-derived growth factor related gene and protein
10/12/2000WO2000059899A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000059543A1 Over-coated chewing gum formulations
10/12/2000WO2000059539A1 Method and means for treating post-polio syndrome
10/12/2000WO2000059536A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000WO2000059508A1 Tolperison-containing, pharmaceutical preparation for oral administration
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059487A2 Flupirtine in the treatment of fibromyalgia and related conditions
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000WO2000020449A3 MODIFIED TGF-β SUPERFAMILY PROTEINS
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2369071A1 Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them
10/12/2000CA2367403A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367109A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000CA2367104A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2365825A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2365040A1 Hob-bp2h compositions, methods and uses thereof
10/11/2000EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
10/11/2000EP1043306A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
10/11/2000EP1043023A1 Viscous compositions containing carbon dioxide
10/11/2000EP1042476A1 Insulin-like growth factor binding protein fragments and the utilization thereof
10/11/2000EP1042352A1 Androgenic steroid compounds and a method of making and using the same
10/11/2000EP1042329A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical, compositions containing them and use for preparing medicines
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042296A1 Substituted isoquinoline derivatives and their use as anticonvulsants
10/11/2000EP1042286A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
10/07/2000CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
10/07/2000CA2303721A1 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
1 ... 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 ... 233